Literature DB >> 8675636

Effects of the apolipoprotein E polymorphism on uptake and transfer of cell-derived cholesterol in plasma.

Y Huang1, A von Eckardstein, S Wu, G Assmann.   

Abstract

The reverse cholesterol transport is initiated by the uptake of cholesterol into minor subfractions of high density lipoproteins (HDL) which contain either apolipoprotein (apo) A-I or apoE as their only apolipoproteins. From these initial acceptors, which are termed prebeta1-LpA-I and gamma-LpE, respectively, cell-derived cholesterol is transferred to LDL via the bulk of HDL termed alpha-LpA-I. In this study we analyzed the effect in plasma of the genetically determined apoE polymorphism on the formation of gamma-LpE, uptake and transfer of cell-derived cholesterol to LDL. Gamma-LpE was immunologically detectable in plasmas of individuals carrying at least one apoE3-allele but not in apoE3-free plasmas. During one minute incubation with [3H]cholesterol-labeled fibroblasts, gamma-LpE of plasmas from apoE3/3 subjects accumulated 7 and 13-fold more radioactivity than the respective fractions in plasmas from apoE2/2- and apoE4/4-subjects, respectively. Totally, 30% less [3H]cholesterol was released into plasmas of apoE2/2 and apoE4/4-individuals as compared with plasmas of apoE3/3-subjects. Moreover, plasmas of apoE3/3 individuals accumulated 50% and 65% more cell-derived [3H]cholesterol in alpha-LpA-I2 than plasmas of apoE4/4 and apoE2/2-subjects, respectively. These results indicate that the apoE-polymorphism is an important determinant of the uptake and transfer of cell-derived cholesterol in plasma.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8675636      PMCID: PMC185976          DOI: 10.1172/JCI118336

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  34 in total

1.  A simple method for the isolation and purification of total lipides from animal tissues.

Authors:  J FOLCH; M LEES; G H SLOANE STANLEY
Journal:  J Biol Chem       Date:  1957-05       Impact factor: 5.157

2.  Apoprotein (E--A-II) complex of human plasma lipoproteins. I. Characterization of this mixed disulfide and its identification in a high density lipoprotein subfraction.

Authors:  K H Weisgraber; R W Mahley
Journal:  J Biol Chem       Date:  1978-09-10       Impact factor: 5.157

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Uptake of apolipoprotein E-containing high density lipoproteins by hepatic parenchymal cells.

Authors:  H Funke; J Boyles; K H Weisgraber; E H Ludwig; D Y Hui; R W Mahley
Journal:  Arteriosclerosis       Date:  1984 Sep-Oct

5.  Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site.

Authors:  K H Weisgraber; T L Innerarity; R W Mahley
Journal:  J Biol Chem       Date:  1982-03-10       Impact factor: 5.157

6.  Biochemical and genetic studies of the apoprotein E secreted by mouse macrophages and human monocytes.

Authors:  S K Basu; Y K Ho; M S Brown; D W Bilheimer; R G Anderson; J L Goldstein
Journal:  J Biol Chem       Date:  1982-08-25       Impact factor: 5.157

Review 7.  High density lipoprotein metabolism.

Authors:  S Eisenberg
Journal:  J Lipid Res       Date:  1984-10       Impact factor: 5.922

8.  Abnormal in vivo metabolism of apolipoprotein E4 in humans.

Authors:  R E Gregg; L A Zech; E J Schaefer; D Stark; D Wilson; H B Brewer
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

9.  Formation of cholesterol- and apoprotein E-enriched high density lipoproteins in vitro.

Authors:  V Gordon; T L Innerarity; R W Mahley
Journal:  J Biol Chem       Date:  1983-05-25       Impact factor: 5.157

10.  Obligatory role of cholesterol and apolipoprotein E in the formation of large cholesterol-enriched and receptor-active high density lipoproteins.

Authors:  C Koo; T L Innerarity; R W Mahley
Journal:  J Biol Chem       Date:  1985-10-05       Impact factor: 5.157

View more
  12 in total

1.  ApoE4 disrupts sterol and sphingolipid metabolism in Alzheimer's but not normal brain.

Authors:  Veera Venkata Ratnam Bandaru; Juan Troncoso; David Wheeler; Olga Pletnikova; Jessica Wang; Kathy Conant; Norman J Haughey
Journal:  Neurobiol Aging       Date:  2007-09-20       Impact factor: 4.673

2.  Secretory processing of amyloid precursor protein is inhibited by increase in cellular cholesterol content.

Authors:  M Racchi; R Baetta; N Salvietti; P Ianna; G Franceschini; R Paoletti; R Fumagalli; S Govoni; M Trabucchi; M Soma
Journal:  Biochem J       Date:  1997-03-15       Impact factor: 3.857

3.  Phenotype-dependent differences in apolipoprotein E metabolism and in cholesterol homeostasis in human monocyte-derived macrophages.

Authors:  P Cullen; A Cignarella; B Brennhausen; S Mohr; G Assmann; A von Eckardstein
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

4.  Differential associations between apolipoprotein E alleles and cerebral myelin content in normative aging.

Authors:  Curtis Triebswetter; Matthew Kiely; Nikkita Khattar; Luigi Ferrucci; Susan M Resnick; Richard G Spencer; Mustapha Bouhrara
Journal:  Neuroimage       Date:  2022-02-09       Impact factor: 6.556

5.  Targeted In Situ Gene Correction of Dysfunctional APOE Alleles to Produce Atheroprotective Plasma ApoE3 Protein.

Authors:  Ioannis Papaioannou; J Paul Simons; James S Owen
Journal:  Cardiol Res Pract       Date:  2012-05-07       Impact factor: 1.866

6.  Cholesterol and matrisome pathways dysregulated in astrocytes and microglia.

Authors:  Julia Tcw; Lu Qian; Nina H Pipalia; Michael J Chao; Shuang A Liang; Yang Shi; Bharat R Jain; Sarah E Bertelsen; Manav Kapoor; Edoardo Marcora; Elizabeth Sikora; Elizabeth J Andrews; Alessandra C Martini; Celeste M Karch; Elizabeth Head; David M Holtzman; Bin Zhang; Minghui Wang; Frederick R Maxfield; Wayne W Poon; Alison M Goate
Journal:  Cell       Date:  2022-06-23       Impact factor: 66.850

7.  Apolipoprotein E and cholesterol in aging and disease in the brain.

Authors:  Elena Posse de Chaves; Vasanthy Narayanaswami
Journal:  Future Lipidol       Date:  2008-10

8.  Low-dose expression of a human apolipoprotein E transgene in macrophages restores cholesterol efflux capacity of apolipoprotein E-deficient mouse plasma.

Authors:  Y Zhu; S Bellosta; C Langer; F Bernini; R E Pitas; R W Mahley; G Assmann; A von Eckardstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

9.  Interaction between VLDL and phosphatidylcholine liposomes generates new γ-LpE-like particles.

Authors:  Agnieszka Ćwiklińska; Barbara Kortas-Stempak; Anna Gliwińska; Anastasis Pacanis; Agnieszka Kuchta; Małgorzata Wróblewska
Journal:  Lipids       Date:  2014-02       Impact factor: 1.880

10.  Apolipoprotein E gene polymorphism influences aggressive behavior in prostate cancer cells by deregulating cholesterol homeostasis.

Authors:  Godwin O Ifere; Renee Desmond; Wendy Demark-Wahnefried; Tim R Nagy
Journal:  Int J Oncol       Date:  2013-08-07       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.